Economic Gains from Health Equity: A Model for Pregnancy and Childbirth Policy Decisions

ImportanceAmerican maternal and neonatal mortality rates are the worst of the worlds high-income countries. These rates are particularly low among patients of color, who have higher Cesarean delivery rates (CDR), higher healthcare costs, and poorer outcomes than White patients. However, common economic analyses do not address interlinked issues and therefore underestimate both the hidden causes of health inequities and the resultant costs to taxpayers. We have therefore designed a more comprehensive health economic model and metric (DEVELOP) that incorporates population health, equity, and economic integration. Design & MeasuresThe DEVELOP model, a childbirth-specific model of the societal economic gain or loss related to healthcare outcomes, incorporates an individuals long-term economic contributions into its calculations of economic benefits. We first used our model to estimate fiscal outcomes if each states CDR for Black patients was lowered to that of White patients. Second, we calculated the costs of "excess" CDR and mortalities among Black patients. Third, we incorporated the additional long-term economic contributions of mothers and their children. ResultsIn the U.S., maternal and neonatal mortality rates and associated costs were higher for Black patients than White patients, and states with the lowest per capita health expenditures showed worse maternal outcomes and higher continuing costs. If the Black patient CDR were reduced to the White patient CDR, taxpayer-funded healthcare programs would save $263 million annually. Reducing the Black patient MMR would improve economic output by $224 million per year, and reducing the Black patient NMR would save $3.1 billion per year, for a combined economic improvement of $3.3 billion annually. Conclusions and RelevanceThe costs of improved prenatal care should be reconceptualized as investments for future economic growth rather than as short-term burdens. Policies blocking reasonable investments in health equity are counterproductive.